Connective tissue diseases: Bosentan for SSc: Long-term outcomes in PAH and efficacy for Raynaud phenomenon

被引：0
|
作者：
Price S.
机构：
来源：
Nature Reviews Rheumatology | 2010年 / 6卷 / 3期
关键词：
D O I：
10.1038/nrrheum.2010.6
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：117 / 117
相关论文
共 50 条
  • [41] Long-term treatment with sitaxsentan in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD)
    Girgis, RE
    Frost, A
    Hill, N
    Langleban, D
    McLaughlin, V
    Oudiz, L
    Coyne, T
    CHEST, 2005, 128 (04) : 218S - 218S
  • [42] The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases
    Rychlik-Golema, W.
    Mastej, K.
    Adamiec, R.
    INTERNATIONAL ANGIOLOGY, 2006, 25 (02) : 221 - 227
  • [43] Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
    Nakayama, Kazuhiko
    Nakajima, Yasuo
    Tanaka, Rika
    Hirata, Ken-ichi
    Emoto, Noriaki
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E371 - E377
  • [44] Effects of Bosentan on quality of life (QoL), safety and tolerability in pulmonary arterial hypertension associated with connective tissue diseases (PAH-CTD).
    Denton, CP
    Gabrielli, A
    Peter, H
    Morganti, A
    Pope, J
    Guillevin, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S587 - S587
  • [45] Long term follow up of a cohort of patients with positive antinuclear antibodies and Raynaud's phenomenon in the absence of connective tissue disease at initial evaluation.
    O'Brien, Marie S.
    Del-Galdo, Francesco
    Jimenez, Sergio A.
    Sandorfi, Nora
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S746 - S746
  • [46] LONG-TERM RECOVERY OF CONNECTIVE-TISSUE AFTER IRRADIATION
    BROWN, JM
    PROBERT, JC
    RADIOLOGY, 1973, 108 (01) : 205 - 206
  • [47] LONG-TERM FOLLOW-UP OF 214 PRIMARY RAYNAUD' S PHENOMENON PATIENTS
    Ortiz Sanjuan, F. M.
    Alcaniz Escandell, C.
    Arevalo Ruales, K. R.
    Chalmeta Verdejo, I.
    De la Rubia Navarro, M.
    Feced Olmos, C.
    Fragio Gil, J. J.
    Gonzalez Mazario, R.
    Gonzalez Puig, L.
    Labrador Sanchez, E.
    Martinez Cordellat, I.
    Negueroles Albuixech, R.
    Grau Garcia, E.
    Ivorra Cortes, J.
    Oiler Rodriguez, J. E.
    Vicens Bernabeu, E.
    Najera Herranz, C.
    Canovas Olmos, I.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1514 - 1514
  • [48] Long-term psychiatric form of mixed connective tissue disease
    Khammassi, N.
    Gargouri, A.
    Gouider, R.
    Hamza, M.
    Cherif, O.
    REVUE NEUROLOGIQUE, 2011, 167 (11) : 856 - 859
  • [49] Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension associated with connective tissue diseases.
    Badesch, D
    Zwicke, D
    Keogh, AM
    Galie, N
    Olschewski, H
    McGoon, MD
    McLaughlin, V
    Oudiz, R
    Frost, AE
    Simonneau, G
    Rubin, LJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S166 - S166
  • [50] Long-term efficacy of bosentan therapy in inoperable chronic thromboembolic pulmonary hypertension
    Post, M. C.
    Plokker, H. W. M.
    Kelder, J. C.
    Snijder, R. J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 562 - 562
12345